Journal
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Volume 70, Issue 3, Pages 449-455Publisher
MOSBY-ELSEVIER
DOI: 10.1016/j.jaad.2013.10.051
Keywords
biomarker; circulating tumor cells; dot-like cytokeratin; Merkel cell carcinoma; neuroendocrine carcinoma of the skin; prognosis
Categories
Funding
- American Cancer Society [RSG-08-115-01-CCE]
- National Institutes of Health (NIH) [K24-CA139052]
- NIH [R01-CA162522-01]
- David and Rosalind Bloom Endowment for Merkel Cell Carcinoma Research
- Michael Piepkorn Endowment Fund
- University of Washington Merkel Cell Carcinoma Patient Gift Fund
Ask authors/readers for more resources
Background: Quantitation of circulating tumor cells (CTCs) has utility in managing breast, colon, and prostate carcinomas. Objective: We sought to determine whether a commercially available CTC assay provides prognostic information in Merkel cell carcinoma (MCC), insight into treatment responses, or both. Methods: We analyzed CTCs in 52 specimens from 34 patients with MCC. Results: The presence of CTCs correlated with extent of disease at blood draw (P = .004). Among 15 patients with regional nodal disease, CTC-negative patients had 80% disease-specific survival at 2 years after the test, versus 29% for CTC-positive patients (P = .015). Among the entire cohort, those without CTCs had 72% MCC-specific survival whereas CTC-positive patients had 25% survival (n = 34, median follow-up 19 months, P = .0003). Fifty seven percent of patients with MCC had a cytokeratin dot visible in 20% or more of CTCs, a feature that was absent among CTCs from other carcinomas (0 of 13 cases). Limitations: CTC assay was performed at variable times after diagnosis and heterogeneity in extent of disease affects interpretability of the data. Conclusion: CTC detection in MCC is feasible and appears to add prognostic information, particularly in patients with regional nodal disease. It may also assist clinical management in certain situations, including differentiating metastatic MCC cells from those of other carcinomas.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available